Product Information
TOBRAMYCIN 300 MG/5 ML AMPULE is a generic product labeled by Ritedose Pharmaceuticals, LLC, priced at $1.0845 per ML under NDC 76204002956. Its NADAC has been published 28 times since Feb 11, 2026.
FDA first approved this application on May 28, 2014. Its Orange Book therapeutic-equivalence code is AN.
Strength
300 mg/5mL
Manufacturer
Ritedose Pharmaceuticals, LLCNDC
76204002956
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA201422FDA Approved
5/28/2014
TE Code
AN
On Market Since
3/25/2025
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has been published 28 times since Feb 11, 2026, and over the history we have for it it has declined 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0845 per ML |
|---|---|
| All-time high | $1.1631 (Feb 11, 2026) |
| All-time low | $1.0672 (Mar 18, 2026) |
| 52-week high | $1.1631 |
| 52-week low | $1.0672 |
| Median price | $1.0881 |
| Average price | $1.0873 |
| Largest weekly change | -4.9% (Feb 18, 2026) |
| Weeks tracked | 28 |
| Tracking since | Feb 11, 2026 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 300 MG/5 ML AMPULE?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 300 MG/5 ML AMPULE, manufactured by Ritedose Pharmaceuticals, LLC, is $1.0845 per ML (NDC 76204002956), effective Aug 19, 2026.
How has the price of TOBRAMYCIN 300 MG/5 ML AMPULE changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has declined 6.8%. It has been tracked across 28 weekly CMS publications since Feb 11, 2026.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 300 MG/5 ML AMPULE?
Since Feb 11, 2026, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has ranged from a low of $1.0672 (Mar 18, 2026) to a high of $1.1631 (Feb 11, 2026), with a median of $1.0881 per ML.
Are there cheaper alternatives to TOBRAMYCIN 300 MG/5 ML AMPULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN 300 MG/5 ML AMPULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TOBRAMYCIN 300 MG/5 ML AMPULE?
TOBRAMYCIN 300 MG/5 ML AMPULE (NDC 76204002956) is labeled by Ritedose Pharmaceuticals, LLC, and CMS classifies it as a generic product.